Mylan’s Launch of a Tecfidera Generic in The United States episode artwork

EPISODE · Aug 31, 2020 · 9 MIN

Mylan’s Launch of a Tecfidera Generic in The United States

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses Mylan’s launch of a Tecfidera generic in the United States.Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads Jessie Ace’s column, DISabled to ENabled, on the things people say when you tell them about your multiple sclerosis diagnosis.=====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info: ChangesInRMS.com=====================================Are you interested in learning more about multiple sclerosis? If so, please visit: multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published Aug 31, 2020

Embed this episode

NOW PLAYING

Mylan’s Launch of a Tecfidera Generic in The United States

0:00 9:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 9 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on August 31, 2020.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!